Magnetar Financial’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Magnetar Financial’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-379,994	Closed	-$3.84M	–	913
2022 Q4	$3.84M	Hold	379,994	–	–	0.07%	292
2022 Q3	$3.77M	Hold	379,994	–	–	0.05%	406
2022 Q2	$3.76K	Sell	379,994 -38,798	-9%	-$380K	0.04%	386
2022 Q1	$4.13M	Sell	418,792 -11,592	-3%	-$114K	0.04%	449
2021 Q4	$4.24M	Buy	+430,384	New	+$4.22M	0.04%	437

Magnetar Financial's BIOT Position: Q1 2023 in Review

Magnetar Financial sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 379,994 shares — an estimated $3.84M sold.

Magnetar Financial first reported a position in BIOT in Q4 2021 and held it in 5 quarters. The position peaked at $4.24M in Q4 2021. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

Magnetar Financial reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Magnetar Financial sold 379,994 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $3.84M.
Magnetar Financial first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q4 2021 and held it in 5 quarters.
Magnetar Financial's Biotech Acquisition Company Class A Ordinary Shares position peaked at $4.24M in Q4 2021.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on Magnetar Financial's 13F filing for Q1 2023, filed 15 May 2023.